Who invested in Semnur Pharmaceuticals?
Semnur Pharmaceuticals's investors include Canaan and Vivo Capital.

United States · Funded startup
2 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Semnur Pharmaceuticals and see its new rounds in your feed.Start following
Funding summaryUpdated 27 Oct 2026
$106Mraised across 2 rounds since 2013, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $6.0M sold, first sale Aug 2013
From the SEC filings it signed: 2 on the team.
On the board, as filediBrent G. AhrensEdgar G. EnglemanJames G. Topper
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Semnur Pharmaceuticals's investors include Canaan and Vivo Capital.
Semnur Pharmaceuticals has raised $106M across 2 rounds since 2013.
Semnur Pharmaceuticals's most recent round was an Undisclosed round of $100M in Sept 2025.
Its most recent round, $100M in Sept 2025, is also its largest on record.
Semnur Pharmaceuticals's first round on record, in Sept 2025, was backed by Canaan and Vivo Capital.
Semnur Pharmaceuticals's latest named round is an Undisclosed round, in Sept 2025.
Semnur Pharmaceuticals is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.